2020
DOI: 10.1038/s41598-020-63377-x
|View full text |Cite|
|
Sign up to set email alerts
|

Design and efficient synthesis of pyrazoline and isoxazole bridged indole C-glycoside hybrids as potential anticancer agents

Abstract: C-glycosides are important class of molecules exhibit diverse biological activities and present as structural motif in many natural products. Two series of new pyrazoline and isoxazole bridged indole C-glycoside molecular hybrids (n = 36) were efficiently synthesized starting from diverse indole 3-carboxaldehydes derived α, β-unsaturated ketone derivatives of β-D-glucosyl-propan-2-one, β-D-galactosyl-propan-2-one and β-D-mannosyl-propan-2-one, reacting with hydrazine hydrate and hydroxyl amine hydrochloride in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
22
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 42 publications
(22 citation statements)
references
References 63 publications
0
22
0
Order By: Relevance
“…Pyrazoline-bridged indole C-glycoside 36 ( Figure 13 ) displayed low micromolar and selective cytotoxicity against MCF-7 (IC 5 0 = 4.67 μM) compared to other breast cancer cell lines [ 92 ]. As a matter of fact, 36 was less active against MDA-MB-231 (IC 50 = 35.5 μM) and far less active against MDA-MB-453 (IC 50 not determined—cell viability was determined at 69.6% at 25 μM).…”
Section: 2-pyrazolinesmentioning
confidence: 99%
“…Pyrazoline-bridged indole C-glycoside 36 ( Figure 13 ) displayed low micromolar and selective cytotoxicity against MCF-7 (IC 5 0 = 4.67 μM) compared to other breast cancer cell lines [ 92 ]. As a matter of fact, 36 was less active against MDA-MB-231 (IC 50 = 35.5 μM) and far less active against MDA-MB-453 (IC 50 not determined—cell viability was determined at 69.6% at 25 μM).…”
Section: 2-pyrazolinesmentioning
confidence: 99%
“…Chalcone derivative 1 was prepared by the reaction of 4-aminoacetophenone with 4pyridinecarboxaldehyde in ethanol, in a presence of sodium hydroxide 40% solution according to Claisen-Schmidt condensation, while the pyrazoline compound (2) was obtained by the reaction of chalcone compound (1) with hydrazine hydrate 80% in ethanol. Schiff's bases (3)(4)(5)(6)(7)(8) were synthesized from the reaction of compound 2 with different aromatic aldehydes in acidic ethanolic solution, while the pyrazoline derivatives (9 and 10) were prepared by the reaction pyrazoline derivative (2) with the corresponding anhydride (maleic or phthalic anhydride) in glacial acetic acid in a presence of anhydrous sodium acetate (Scheme 1). The structures of obtained compounds were confirmed by spectral analysis (see experimental section).…”
Section: Resultsmentioning
confidence: 99%
“…The development of heterocyclic chemistry is very rapid, especially in the development of synthetic methods and the biological activity of synthetic materials [3]. Pyrazoline has been widely incorporated into the structure of many important medical and biochemical reagents that have been effectively utilized as anti-bacterial [4], anti-inflammatory [5], anti-viral [6], anti-fungal [7], anti-cancer [8], analgesic and insecticidal agents [9]. In the last few years, a significant and important portion of research in the field of heterocyclic chemistry has been dedicated to pyrazolines and their derivatives, especially those linked by various functional groups such as imine group (Schiff's-Base).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Glycosides appended to isoxazoles in the hybrid compounds 109 (Figure 18) mainly deliberated as anticancer agents displayed marked inhibition of COX‐2 enzyme, superior than the commercial drug celecoxib. Molecular docking analysis on test compounds in the active site of COX‐2 isoenzyme revealed hydrogen bonding interactions and hydrophobic interactions between the carbohydrate moiety and the active site residues (Kumari et al, 2020). Isoxazole based scaffolds 110–111a–b (Figure 18) validated the selective COX‐2 inhibition profile of isoxazole nucleus by displaying potent activities in submicromolar range.…”
Section: Selective Cox‐2 Inhibitors Based On Azole Nucleusmentioning
confidence: 99%